Scottsdale, Ariz. (August 28, 2023) – HonorHealth, a leading health system in the greater Phoenix area, is the first and only healthcare provider in Arizona approved to perform percutaneous transmural arterial bypass (PTAB) therapy. PTAB therapy received FDA approval in July 2023.
This leading-edge procedure provides a new treatment option for patients with complex peripheral artery disease who have a blockage in the arteries supplying blood to their foot, enabling surgeons to bypass lesions in the superficial femoral artery and use stents routed through the femoral vein to restore blood flow to the leg. PTAB can be a good solution for patients with long obstructions in the superficial femoral artery, those with previously failed endovascular procedures, and those who may not be ideal candidates for surgical bypass.
“This procedure is a minimally invasive approach that utilizes endovascular techniques to create a bypass around the diseased area, which allows our patients to recover much faster and likely allow them to go home within a day versus a multi-night stay in the hospital,” says Venkatesh Ramaiah, MD, HonorHealth vascular surgeon, and a principal investigator in the multi-year FDA study. “I've been in practice for almost 25 years, and we've been heavily involved in the education and research needed to develop and introduce new technology or new devices, like PTAB, into the market.”
“It’s a great privilege to work at a place where we‘re continuously innovating. The PTAB procedure is a perfect example,” says Hasan Aldailami, MD, a vascular surgeon with the HonorHealth Medical Group, who is also trained to perform this procedure. “We’re now able to provide our patients with therapies that just a few months ago weren’t available. We can deliver the same benefits of an open bypass procedure with less risk because it’s completely percutaneous, requiring a single incision in the groin and another small incision in the calf area.”
“It's a fantastic thing that he did,” says Edward Mann, the first Arizonan to undergo the procedure upon FDA approval. “I went through multiple [other] procedures, but the stents kept closing, and I was right back to where I started. The night before my fourth procedure, the FDA approval came through, and Dr. Ramaiah was able to do the new surgery. After a one-night stay in the hospital, my wife took me home, and now I’m walking and doing all the things that I couldn’t do before because of the pain.”
